impact factor, citescore
logo
 

Letters to the Editor

 

Novel use of abrocitinib in refractory ulcerative panniculitis with vasculitis: a case report


1, 2

 

  1. The Second School of Clinical Medicine, Zhejiang Chinese Medical University, Zhejiang; and Department of Rheumatology and Immunology, Center for General Practice Medicine, Zhejiang Provincial People's Hospital (Affiliated People's Hospital, Hangzhou Medical College), Zhejiang, China.
  2. Department Rheumatology and Immunology, Center for General Practice Medicine, Zhejiang Provincial People’s Hospital (Affiliated People’s Hospital, Hangzhou Medical College), Zhejiang; Zhejiang Provincial Key Laboratory of Traditional Chinese Medicine Cultivation forArthritis Diagnosis and Treatment, Zhejiang; and Rheumatology and Immunology Research Institute, Hangzhou Medical College, Zhejiang, China. yingzh2021@163.com

CER18859
Letters to the Editor

Free to view
(click on article PDF icon to read the article)

PMID: 40470569 [PubMed]

Received: 25/04/2025
Accepted : 19/05/2025
In Press: 31/05/2025

Rheumatology Article